Literature DB >> 12019137

Lentivirus lytic peptide 1 perturbs both outer and inner membranes of Serratia marcescens.

Shruti M Phadke1, Vanja Lazarevic, Caroline C Bahr, Kazi Islam, Donna Beer Stolz, Simon Watkins, Sarah B Tencza, Hans J Vogel, Ronald C Montelaro, Timothy A Mietzner.   

Abstract

Bis-lentivirus lytic protein 1 (Bis-LLP1) and polymyxin B exhibited similar killing activities against Serratia marcescens. By electron microscopy, bis-LLP1 interacted with the outer and cytoplasmic bacterial membranes, while polymyxin B affected only the outer membrane. The results of standard biochemical probes supported the findings of the electron microscopy studies, suggesting that these antimicrobial peptides have different mechanisms of action.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12019137      PMCID： PMC127261          DOI： 10.1128/AAC.46.6.2041-2045.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Lentivirus-derived antimicrobial peptides: increased potency by sequence engineering and dimerization.

Authors:  S B Tencza; D J Creighton; T Yuan; H J Vogel; R C Montelaro; T A Mietzner
Journal:  J Antimicrob Chemother       Date:  1999-07       Impact factor: 5.790

2.  Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa.

Authors:  L Zhang; P Dhillon; H Yan; S Farmer; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 3.  Cationic antimicrobial peptides: towards clinical applications.

Authors:  R E Hancock
Journal:  Expert Opin Investig Drugs       Date:  2000-08       Impact factor: 6.206

4.  Mechanisms of antibacterial action of tachyplesins and polyphemusins, a group of antimicrobial peptides isolated from horseshoe crab hemocytes.

Authors:  M Ohta; H Ito; K Masuda; S Tanaka; Y Arakawa; R Wacharotayankun; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 5.  The interaction of the antimicrobial peptide gramicidin S with lipid bilayer model and biological membranes.

Authors:  E J Prenner; R N Lewis; R N McElhaney
Journal:  Biochim Biophys Acta       Date:  1999-12-15

6.  Effect of polymyxin B on outer membranes of Serratia marcescens: morphological alterations of the outer membranes and their lipopolysaccharide components.

Authors:  D A Weber; M J Nadakavukaren; J C Tsang
Journal:  Microbios       Date:  1976

7.  Interaction of cationic peptides with bacterial membranes.

Authors:  S Fidai; S W Farmer; R E Hancock
Journal:  Methods Mol Biol       Date:  1997

8.  Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism.

Authors:  H E Gilleland; L B Farley
Journal:  Can J Microbiol       Date:  1982-07       Impact factor: 2.419

9.  Calmodulin-binding function of LLP segments from the HIV type 1 transmembrane protein is conserved among natural sequence variants.

Authors:  S B Tencza; T A Mietzner; R C Montelaro
Journal:  AIDS Res Hum Retroviruses       Date:  1997-02-10       Impact factor: 2.205

10.  Electron microscopic observations of polysaccharide components in polymyxin B treated outer membranes from Serratia marcescens.

Authors:  D A Weber; M J Nadakavukaren; J C Tsang
Journal:  J Antibiot (Tokyo)       Date:  1979-01       Impact factor: 2.649
View more
  11 in total

1.  Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.

Authors:  Berthony Deslouches; Mary L Hasek; Jodi K Craigo; Jonathan D Steckbeck; Ronald C Montelaro
Journal:  J Med Microbiol       Date:  2016-04-05       Impact factor: 2.472

2.  Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria.

Authors:  Karen F Novak; William J Diamond; Sreenatha Kirakodu; Rebecca Peyyala; Kimberly W Anderson; Ronald C Montelaro; Timothy A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

3.  Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.

Authors:  Berthony Deslouches; Jonathan D Steckbeck; Jodi K Craigo; Yohei Doi; Timothy A Mietzner; Ronald C Montelaro
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

4.  Evaluation of amoebicidal potential of Paneth cell cryptdin-2 against Entamoeba histolytica.

Authors:  Simran Preet; Sanjay Bharati; Geeta Shukla; Ashwani Koul; Praveen Rishi
Journal:  PLoS Negl Trop Dis       Date:  2011-12-20

5.  Bacterial membrane activity of α-peptide/β-peptoid chimeras: influence of amino acid composition and chain length on the activity against different bacterial strains.

Authors:  Line Hein-Kristensen; Kolja M Knapp; Henrik Franzyk; Lone Gram
Journal:  BMC Microbiol       Date:  2011-06-22       Impact factor: 3.605

Review 6.  Mechanistic Landscape of Membrane-Permeabilizing Peptides.

Authors:  Shantanu Guha; Jenisha Ghimire; Eric Wu; William C Wimley
Journal:  Chem Rev       Date:  2019-01-09       Impact factor: 72.087

7.  Antibacterial Activity of AI-Hemocidin 2, a Novel N-Terminal Peptide of Hemoglobin Purified from Arca inflata.

Authors:  Chunlei Li; Jianhua Zhu; Yanqing Wang; Yuyan Chen; Liyan Song; Weiming Zheng; Jingjing Li; Rongmin Yu
Journal:  Mar Drugs       Date:  2017-06-29       Impact factor: 5.118

8.  Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α4-Short, in a Murine Model of Respiratory Infection.

Authors:  Shasha Jiang; Berthony Deslouches; Chen Chen; Matthew E Di; Y Peter Di
Journal:  mBio       Date:  2019-04-09       Impact factor: 7.867

Review 9.  Cytopathic mechanisms of HIV-1.

Authors:  Joshua M Costin
Journal:  Virol J       Date:  2007-10-18       Impact factor: 4.099

10.  Modulation of proinflammatory activity by the engineered cationic antimicrobial peptide WLBU-2.

Authors:  Shruti M Paranjape; Thomas W Lauer; Ronald C Montelaro; Timothy A Mietzner; Neeraj Vij
Journal:  F1000Res       Date:  2013-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.